Milupa GmbHMay 7, 2022

FDA 483 - Milupa GmbH - May 07, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Milupa GmbH

Record Details

An FDA inspection of Milupa GmbH in Fulda, Germany, revealed a significant issue with microbiological control during the production of a specific product. The firm failed to establish adequate process controls, specifically critical limits for temperature and hold time, to prevent the potential for microbial growth. This indicates a serious concern regarding product safety and quality.

Company: Milupa GmbH
Inspection Date: May 7, 2022
Product Type: Other
Office: Office of Biological Products Operations - Division I
People: Jane Chen (Investigator)
Karen M. Labounty (Investigator)

Open in Dashboard

ID · 0c715c20-e237-4378-be5d-65b03f586e75